Operating Income (Loss) in USD of Lipocine Inc. from Q1 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Lipocine Inc. quarterly/annual Operating Income (Loss) history and change rate from Q1 2012 to Q3 2025.
  • Lipocine Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$3,361,040.000, a 27.8% decline year-over-year.
  • Lipocine Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$6,310,100.000, a 19.2% decline year-over-year.
  • Lipocine Inc. annual Operating Income (Loss) for 2024 was -$1,155,035.000, a 93.6% increase from 2023.
  • Lipocine Inc. annual Operating Income (Loss) for 2023 was -$17,930,957.000, a 48% decline from 2022.
  • Lipocine Inc. annual Operating Income (Loss) for 2022 was -$12,119,375.000, a 485% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Lipocine Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$6,310,100 -$3,361,040 -$730,567 -27.8% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 -$5,579,533 -$2,404,353 +$888,215 +27% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 -$6,467,748 -$2,090,184 -$5,312,713 -1.6% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$1,155,035 $1,545,477 +$4,138,830 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025
Q3 2024 -$5,293,865 -$2,630,473 +$4,412,893 +62.7% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 -$9,706,758 -$3,292,568 +$663,037 +16.8% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025
Q1 2024 -$10,369,795 $3,222,529 +$7,561,162 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$17,930,957 -$2,593,353 -$32,520 -1.3% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 -$17,898,437 -$7,043,366 -$4,143,995 -1.4% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$13,754,442 -$3,955,605 -$428,074 -12.1% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$13,326,368 -$4,338,633 -$1,206,993 -38.5% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 -$12,119,375 -$2,560,833 -$15,344,781 -1.2% 01 Oct 2022 31 Dec 2022 10-K 07 Mar 2024
Q3 2022 $3,225,406 -$2,899,371 +$634,302 +18% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023
Q2 2022 $2,591,104 -$3,527,531 -$537,252 -18% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 $3,128,356 -$3,131,640 -$17,147 -0.55% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $3,145,503 $12,783,948 +$17,585,622 01 Oct 2021 31 Dec 2021 10-K 10 Mar 2023
Q3 2021 -$14,440,119 -$3,533,673 +$841,383 +19.2% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 -$15,281,502 -$2,990,279 +$1,232,240 +29.2% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 -$16,513,742 -$3,114,493 +$1,482,522 +32.2% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 -$17,996,264 -$4,801,674 -$1,353,423 -39.2% 01 Oct 2020 31 Dec 2020 10-K 09 Mar 2022
Q3 2020 -$16,642,841 -$4,375,056 -$1,399,368 -47% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$15,243,473 -$4,222,519 -$871,916 -26% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 -$14,371,557 -$4,597,015 -$1,471,267 -47.1% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 -$12,900,290 -$3,448,251 -$276,884 -8.7% 01 Oct 2019 31 Dec 2019 10-K 11 Mar 2021
Q3 2019 -$12,623,406 -$2,975,688 -$622,632 -26.5% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 -$12,000,774 -$3,350,603 -$186,194 -5.9% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020
Q1 2019 -$11,814,580 -$3,125,748 -$488,762 -18.5% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q4 2018 -$11,325,818 -$3,171,367 +$2,231,017 +41.3% 01 Oct 2018 31 Dec 2018 10-K 06 Mar 2019
Q3 2018 -$13,556,835 -$2,353,056 +$2,413,003 +50.6% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 -$15,969,838 -$3,164,409 +$2,976,209 +48.5% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019
Q1 2018 -$18,946,047 -$2,636,986 +$2,271,929 +46.3% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019
Q4 2017 -$21,217,976 -$5,402,384 -$2,387,294 -79.2% 01 Oct 2017 31 Dec 2017 10-K 06 Mar 2019
Q3 2017 -$18,830,682 -$4,766,059 -$1,479,839 -45% 01 Jul 2017 30 Sep 2017 10-K 06 Mar 2019
Q2 2017 -$17,350,843 -$6,140,618 -$325,498 -5.6% 01 Apr 2017 30 Jun 2017 10-K 06 Mar 2019
Q1 2017 -$17,025,345 -$4,908,915 +$2,161,489 +30.6% 01 Jan 2017 31 Mar 2017 10-K 06 Mar 2019
Q4 2016 -$19,186,834 -$3,015,090 +$1,681,008 +35.8% 01 Oct 2016 31 Dec 2016 10-K 12 Mar 2018
Q3 2016 -$20,867,842 -$3,286,220 +$3,147,768 +48.9% 01 Jul 2016 30 Sep 2016 10-K 12 Mar 2018
Q2 2016 -$24,015,610 -$5,815,120 -$1,537,377 -35.9% 01 Apr 2016 30 Jun 2016 10-K 12 Mar 2018
Q1 2016 -$22,478,233 -$7,070,404 -$4,096,165 -1.4% 01 Jan 2016 31 Mar 2016 10-K 12 Mar 2018
Q4 2015 -$18,382,068 -$4,696,098 -$635,819 -15.7% 01 Oct 2015 31 Dec 2015 10-K 06 Mar 2017
Q3 2015 -$17,746,249 -$6,433,988 -$2,315,637 -56.2% 01 Jul 2015 30 Sep 2015 10-K 06 Mar 2017
Q2 2015 -$15,430,612 -$4,277,743 +$2,731,819 +39% 01 Apr 2015 30 Jun 2015 10-K 06 Mar 2017
Q1 2015 -$18,162,431 -$2,974,239 +$2,318,383 +43.8% 01 Jan 2015 31 Mar 2015 10-K 06 Mar 2017
Q4 2014 -$20,480,814 -$4,060,279 +$352,227 +8% 01 Oct 2014 31 Dec 2014 10-K 06 Mar 2017
Q3 2014 -$20,833,041 -$4,118,351 -$572,586 -16.1% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015
Q2 2014 -$20,260,455 -$7,009,562 -$5,636,350 -4.1% 01 Apr 2014 30 Jun 2014 10-Q 11 Aug 2015
Q1 2014 -$14,624,105 -$5,292,622 -$3,940,475 -2.9% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015
Q4 2013 -$10,683,630 -$4,412,506 01 Oct 2013 31 Dec 2013 10-K 11 Mar 2015
Q3 2013 -$3,545,765 -$2,530,764 -2.5% 01 Jul 2013 30 Sep 2013 10-Q 10 Nov 2014
Q2 2013 -$1,373,212 01 Apr 2013 30 Jun 2013 10-Q 13 Aug 2014
Q1 2013 -$1,352,147 -$1,347,335 01 Jan 2013 31 Mar 2013 10-Q 13 May 2014
Q3 2012 -$1,015,001 01 Jul 2012 30 Sep 2012 10-Q 13 Nov 2013
Q1 2012 -$4,812* 01 Jan 2012 31 Mar 2012 10-Q 14 May 2012

Lipocine Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1,155,035 +$16,775,922 +93.6% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025
2023 -$17,930,957 -$5,811,582 -48% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025
2022 -$12,119,375 -$15,264,878 -4.9% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024
2021 $3,145,503 +$21,141,767 01 Jan 2021 31 Dec 2021 10-K 10 Mar 2023
2020 -$17,996,264 -$5,095,974 -39.5% 01 Jan 2020 31 Dec 2020 10-K 09 Mar 2022
2019 -$12,900,290 -$1,574,471 -13.9% 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2021
2018 -$11,325,819 +$9,892,157 +46.6% 01 Jan 2018 31 Dec 2018 10-K 13 Mar 2020
2017 -$21,217,976 -$2,031,142 -10.6% 01 Jan 2017 31 Dec 2017 10-K 06 Mar 2019
2016 -$19,186,834 -$804,766 -4.4% 01 Jan 2016 31 Dec 2016 10-K 06 Mar 2019
2015 -$18,382,068 +$2,098,746 +10.2% 01 Jan 2015 31 Dec 2015 10-K 12 Mar 2018
2014 -$20,480,814 -$9,797,184 -91.7% 01 Jan 2014 31 Dec 2014 10-K 06 Mar 2017
2013 -$10,683,630 -$14,560,906 -3.8% 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2015
2012 $3,877,276 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.